Sort by
Refine Your Search
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
nationalities represented in a student body of 43,800 students. Our main location in Central London has recently been augmented by a campus on the Queen Elizabeth Olympic Park. The UCL Faculty of Engineering is
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The Department of Translational Neuroscience and Stroke at UCL is dedicated to understanding the underlying mechanisms of neurological diseases and developing innovative treatments
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology
-
About us UCL Biochemical Engineering (UCL-BE) is a world leader in bioprocessing, where researchers harness cutting-edge facilities and industry partnerships to transform breakthroughs in biology